Navigation Links
Poniard Announces Publication of Results of Picoplatin Phase 2 Study in Journal of Clinical Oncology
Date:4/20/2009

tients with metastatic colorectal cancer and the other in patients with castration-resistant (or hormone-refractory) prostate cancer. Oral picoplatin is being evaluated in a Phase 1 clinical trial in solid tumors.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. For additional information please visit http://www.poniard.com.

This release contains forward-looking statements, including statements regarding the Company's results of clinical trials, business objectives and strategic goals, drug development plans, the potential safety and efficacy of its products in development and commercialization strategy. The Company's actual results may differ materially from those indicated in these forward-looking statements based on a number of factors, including risks and uncertainties associated with the Company's research and development activities; the results of clinical testing; the receipt and timing of FDA and other required regulatory approvals; the market's acceptance of the Company's proposed products; the Company's anticipated operating losses, need for future capital and ability to obtain future funding; competition from third parties; the Company's ability to preserve and protect intellectual property rights; the Company's dependence on third-party manufacturers and suppliers; the Company's lack of sales and marketing experience; the Company's ability to attract and retain key personnel; changes in technology, government regulation and general market conditions; and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including the Company's Annual Report on
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update
3. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
4. Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin
5. Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
6. Poniard Pharmaceuticals Receives Going Concern Qualification
7. Poniard Pharmaceuticals to Present at Needham & Companys Cancer Therapeutics: Today & Tomorrow Conference
8. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
9. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
10. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
11. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)...ps to eliminate triggers, experts advise , ...t Scrooges, but people with allergies and asthma c...s and need to take special steps to prevent sneezi... of Allergy, Asthma and Immunology (ACAAI). , Thos...o decorate with artificial plants, but both live a...
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
... It is a fact that,Multi-Drug Resistant organisms ...trochemical medicines. According to the World Heal...s are responsible for needless increases,in hospit...ions to this growing problem., (Photo: http://ww...
...eflex Stock, the leading independent supplier of r...tions has today (October 1, 2008) launched a new c...uded in the new collections is Heritage Images, an...ommercially for the first time. , ...
...ed by researchers at Mayo Clinic shows that obese ... response to the weight loss drug sibutramine, whi...le or no weight. , The findings are published in ...sured the impact of two different dosage levels of...
...xoGen, Inc., a leader in the development of treatm...uries, announced today that the American Associati...stigious AATB accreditation. This accreditation af...ue. , ALACHUA, Fla. (Bus...
...Emergency Service,Center (DESC) is pleased to rele...e. DESC uses CHASERS to store and manage informati... Created by DESC, CHASERS is both proven and a wor...tains information on,over 70,000 clients served by...
...he second time in presidential debate history, a f...ale opponent. While Geraldine Ferraro broke new gr...male to be included as part of a major party ticke...evealing study by a University of Missouri researc...
Other Medicine News:Health News:Argentyn 23(R) Homeopathic First Aid Gel - Another World's First by Natural-Immunogenics Corp. for Healthcare Professionals 2Health News:Reflex Stock Launches Exciting New Editorial Image Collections to the Worldwide Publishing Industry 2Health News:Genes affect weight loss drug effectiveness 2Health News: AxoGen Awarded Accreditation from American Association of Tissue Banks : Decision Affirms AxoGen's Commitment to Safety and Ethicality in the Development and Distribution of AVANCE Nerve Graft for Treatment of Peripheral Nerve Injuries 2Health News: AxoGen Awarded Accreditation from American Association of Tissue Banks : Decision Affirms AxoGen's Commitment to Safety and Ethicality in the Development and Distribution of AVANCE Nerve Graft for Treatment of Peripheral Nerve Injuries 3Health News:Downtown Emergency Service Center Releases CHASERS, Free Software for Homeless Service Management and Beyond 2Health News:Downtown Emergency Service Center Releases CHASERS, Free Software for Homeless Service Management and Beyond 3Health News:Gender is a relative term in politics, MU study finds 2
(Date:12/4/2009)STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
(Date:12/4/2009)TARRYTOWN, N.Y., Dec. 4 Bayer Diabetes Care today announced the three grand prize winners of Bayer,s "Express Your Simple Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the winn
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 1New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 2New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 3New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 4New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 5New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 6Hobby Lobby Selects Concentra to Open Health Center 62350 1Hobby Lobby Selects Concentra to Open Health Center 62350 2Hobby Lobby Selects Concentra to Open Health Center 62350 3US Farms Inc Announces Marketing Agreement With Micro Lending Institution Angels In Action 62347 1US Farms Inc Announces Marketing Agreement With Micro Lending Institution Angels In Action 62347 2US Farms Inc Announces Marketing Agreement With Micro Lending Institution Angels In Action 62347 3
...eague,s historic Personhood Conference is featurin...earch and regenerative medicine. , , (Logo: htt...OGO ) , , Dr. Theresa Deisher, founder and CEO o...Pharmaceutical Institute, is speaking on over 17 y...ry, production and commercialization of human ther...
...x Foundation for Parkinson,s Research awarded abou... will test drugs already approved in other disease...son,s disease. Because both drugs being tested are...tential to move swiftly toward regulatory approval...ective in PD. , , One funded team will investigat...
Other Medicine Technology:Stem Cell Pioneer to Speak to A.L.L. Personhood Conference 2Michael J. Fox Foundation Awards $2.9 Million for Two New Parkinson's Disease Clinical Trials 2
... Orthosis Until now, laborious custom fabrication ...tability was limited and modifications in response...d cumbersome.,The GunSlinger evolved from two yea...ching hospital. This orthosis can be quickly adjus...
...gned for the functional management of grade I, II,...e-inflated aircell, the brace provides focused, pn... while supporting the arm and shoulder. A detachab...additional arm support and helps to unload the wai...
...to treat or help prevent lower extremity disorder..., foot drop, contractures and pressure necrosis at...s a comfortable wicking interface for the patient....ed into a vertical configuration when not needed o...
... ankle. This simple concept is the cornerstone of ... you lock the heel with our patent-pending Stablel...d comfort your patient will experience walking in ...the heel and supports the posterior aspect of the ...
Medicine Products: